Infection by SARS-CoV-2 triggers the creation of antibodies in a two-part response:

• early antibodies (IgM)
• late antibodies (IgG)

With assistance from helper T cells, B cells differentiate into plasma B cells to produce these antibodies against the SARS-CoV-2 antigens.